PuriCore Announces Final Results

Pennsylvania--(Marketwire - April 28, 2009) -

 PuriCore plc Final Results for the Year Ended 31 December 2008 Sales Increase 80.9% and Cashflow Significantly Improved MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 28 April 2009 - PuriCore (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively and naturally kill infectious pathogens without causing harm to human health or the environment, announces its Final Results for the year ended 31 December 2008 and the availability of its 2008 annual report on its website. PuriCore also announced today its Interim Management Statement for Q1 2009 (see separate release). Financial Highlights . Revenues up 80.9% to USD33.7 million (2007: USD18.6 million) - Food Safety sales up 147% to USD19.4 million (2007: USD7.9 million) - Endoscopy sales up 34.9% to USD13.8 million (2007: USD10.3 million) . Operational cash outflow halved to USD6.6 million (2007: USD14.1 million) . SG&A expenses down 10% (net of depreciation, amortisation, and non-cash share option expense) Operational Highlights . Sterilox Food Safety Systems installed in more than 2,400 retail stores (with two of the top-five chains implementing full network rollouts) . Won Food Safety contracts totaling USD35 million including all Safeway’s North American stores . Sterilox Systems used in a quarter of UK NHS endoscopy departments . More than 4,000 wound therapy patients treated: clinicians report no adverse side effects . New Sterilox Food Safety System Model 2200 launched . Completed fundraisings - GBP8.4 million in equity - USD9.7 million in debt . Sterilox Solution found effective against H5N1 avian influenza . Sterilox System approved for organic food processing by the Organic Materials Review Institute Greg Bosch, Chief Executive of PuriCore, said:"PuriCore delivered a strong performance in 2008, resulting in record revenues in both the US Food Safety and UK Endoscopy core businesses whilst operating expenses were more than halved. In the current year, we have continued to see increasing revenues and remain focused on improving gross margins whilst leveraging our operating expenses. We believe we are well-positioned to deliver another strong year of revenue growth and achieve profitability for both our core businesses during 2009.” Enquiries: Ben Brewerton Greg Bosch, CEO Susan Quigley Darren Weiss, VP Finance Financial Dynamics PuriCore +44 (0) 20 7831 3113 +1 484 321 2700 Click on, or paste the following link into your web browser, to view the associated PDF document. http://www.rns-pdf.londonstockexchange.com/rns/2473R_1-2009-4-27.pdf This information is provided by RNS The company news service from the London Stock Exchange END